Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Injectafer (ferric carboxymaltose; Vifor/Luitpold Pharmaceuticals/Zeria) Drug Analysis 2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 19 Feb 18

The "Drug Analysis: Injectafer" drug pipelines has been added to ResearchAndMarkets.com's offering.

Injectafer (ferric carboxymaltose; Vifor/Luitpold Pharmaceuticals/Zeria) is an iron maintenance treatment used to help elevate hemoglobin levels in patients with anemia in chronic kidney disease (CKD).

It is administered intravenously and is dissociated into iron and sucrose once in circulation. The iron is transported via transferrin to erythroid precursor cells. Erythroid precursor cells incorporate the iron into hemoglobin as the cell matures into a red blood cell. Iron maintenance therapies like Injectafer have achieved widespread use by improving both the safety and cost-efficiency associated with treating anemia in CKD, reducing the doses of erythropoiesis-stimulating agents required to correct and maintain hemoglobin levels.

Key Topics Covered:

List of Figures

Figure 1: Injectafer for anemia in chronic kidney disease - SWOT analysis

Figure 2: Drug assessment summary of Injectafer for anemia in chronic kidney disease

Figure 3: Drug assessment summary of Injectafer for anemia in chronic kidney disease

Figure 4: Injectafer sales for anemia in chronic kidney disease across the US and five major EU markets, by country, 2015-24

List of Tables

Table 1: Injectafer drug profile

Table 2: Injectafer Phase III data in anemia in chronic kidney disease

Table 3: Injectafer sales for anemia in chronic kidney disease across the US and five major EU markets, by country ($m), 2015-24

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/w5n4j2/injectafer?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180219005467/en/

Business Wire
www.businesswire.com

Last updated on: 19/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.